Your session is about to expire
← Back to Search
Positive Behavior Management Toolkit for ADHD
N/A
Waitlist Available
Led By Gwendolyn M Lawson, PhD
Research Sponsored by Children's Hospital of Philadelphia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Has mental capacity to provide consent for the participation of child in the study and for their own participation in the study
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, midpoint (i.e., up to 7 weeks from resource package receipt), endpoint (i.e, at least 8 weeks from resource package receipt)
Awards & highlights
Study Summary
This trial is testing a new way to help teachers manage disruptive behaviors in kids, and to see if it leads to better mental health outcomes for those children.
Who is the study for?
This trial is for K-5 teachers in Philadelphia schools and parents or guardians of children with ADHD. Teachers must be able to consent, assess the child's behavior, and not have students with intellectual disabilities, acute risk of harm to self or others, or primary concerns of psychosis or autism.Check my eligibility
What is being tested?
The study tests a Positive Behavior Management Toolkit designed to help teachers manage ADHD behaviors in the classroom. Teachers will either receive this toolkit or continue with their usual support methods while effects on implementation and child mental health are measured.See study design
What are the potential side effects?
Since this trial involves educational strategies rather than medical treatments, there aren't traditional side effects. However, there may be varying levels of effectiveness and potential stress related to adapting new teaching practices.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am mentally capable of giving consent for my child and myself to participate in the study.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, midpoint (i.e., up to 7 weeks from resource package receipt), endpoint (i.e, at least 8 weeks from resource package receipt)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, midpoint (i.e., up to 7 weeks from resource package receipt), endpoint (i.e, at least 8 weeks from resource package receipt)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acceptability of Intervention Measure (AIM)
Change in Academic Productivity
Change in Student-Teacher Relationship
+8 moreSecondary outcome measures
Change in Academic Success
Change in Homework Performance
Change in caregiver-reported ADHD Symptoms
+2 moreOther outcome measures
Potential mediators of teacher implementation outcomes
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Implementation Resource Package GroupExperimental Treatment1 Intervention
Teachers in this group will receive an implementation support package and receive support in using it within their classroom management practice. Also within the intervention group (experimental), will be students nested in the classrooms of the teachers that are assigned to the intervention group.
Group II: Control GroupActive Control1 Intervention
Within the control group (no intervention), teachers in this group will not receive the implementation support package nor extra support during the study period. They will continue to receive implementation support as usual. Also within the control group (no intervention) will be students nested in the classrooms of the teachers that are assigned to the control group.
Find a Location
Who is running the clinical trial?
Children's Hospital of PhiladelphiaLead Sponsor
708 Previous Clinical Trials
8,581,185 Total Patients Enrolled
7 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
2,448 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
National Institute of Mental Health (NIMH)NIH
2,784 Previous Clinical Trials
2,689,185 Total Patients Enrolled
95 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
20,045 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Gwendolyn M Lawson, PhDPrincipal InvestigatorChildren's Hospital of Philadelphia/University of Pennsylvania Perelman School of Medicine
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am mentally capable of giving consent for my child and myself to participate in the study.I know the child well enough to provide detailed information about them.You are at immediate risk of harming yourself or others, and need more urgent help than this study can provide.The teacher has noticed that the student has trouble paying attention, is very active, or acts without thinking.Your main problem is having psychotic or autism spectrum disorders.
Research Study Groups:
This trial has the following groups:- Group 1: Control Group
- Group 2: Implementation Resource Package Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any available slots for participants in this experiment?
"Clinicaltrials.gov has revealed that this particular medical research project, which was initially made public on September 20th 2022 and last modified on November 22nd 2022, is not presently recruiting. Nevertheless, there are still 112 additional clinical trials open to new participants at the moment."
Answered by AI
What is the expected result of this trial?
"The primary endpoint of this investigation will judge the Acceptability of Intervention Measure (AIM) over an 8-week period. Furthermore, researchers are also interested in assessing Change in caregiver-reported ADHD Symptoms with a National Institute for Children's Health Quality Vanderbilt Scale - Parent Version consisting of 18 items rated on a 4-point scale; Change in Homework Performance using the Homework Performance Questionnaire - Parent Version which has 9 items and is scored similarly; as well as Change in teacher-reported ADHD Symptoms through a Teacher version of the same inventory."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger